Get Your Personalized Supplement StackSupplement Stack Quiz

Reishi Mycelia

Also known as: Reishi mushroom, Lingzhi, Reishi mycelia, Ganoderma lucidum

Overview

Reishi mycelia are the filamentous vegetative structures of Ganoderma lucidum, a basidiomycete fungus widely cultivated in East Asia. This stage represents the active growth phase before the formation of the mushroom's fruiting body. Both the mycelia and fruiting bodies contain bioactive compounds, primarily polysaccharides, triterpenoids, and peptides, which are believed to contribute to its health benefits. Traditionally, Reishi has been used in East Asian medicine for immune modulation, metabolic health, and promoting longevity. Modern supplements containing Reishi mycelia are primarily marketed for immune support, metabolic regulation, and cardiovascular health. The mushroom's purported effects stem from its bioactive compounds, which are thought to possess antioxidant, anti-inflammatory, and immunomodulatory properties. While research on Reishi is ongoing, the current evidence base is considered moderate, with multiple clinical trials existing but often exhibiting heterogeneous designs and outcomes. Systematic reviews and meta-analyses are emerging, yet they frequently highlight the need for more rigorous and consistent studies to solidify the evidence for its various applications.

Benefits

Reishi mycelia show some evidence of beneficial effects, particularly in healthy adults. A meta-analysis indicated statistically significant reductions in total cholesterol and serum glutamic-pyruvic transaminase (SGPT), suggesting potential lipid-lowering and liver enzyme modulating effects. However, the clinical relevance and effect sizes of these changes require further investigation. Immunomodulatory effects are also suggested by preclinical and some clinical studies, though strong clinical evidence in humans is still lacking. Secondary benefits may include potential regulatory effects on gut microbiota, which could indirectly influence metabolic and cardiovascular health, as well as general anti-inflammatory and antioxidant properties. For healthy adults, modest improvements in cholesterol and liver enzymes have been observed. However, for populations with metabolic syndrome, type 2 diabetes, or established cardiovascular disease, the evidence for significant benefit is inconclusive or shows no clear effect. Benefits, when observed, typically manifest after several weeks to a few months of consistent supplementation.

How it works

The primary mechanisms of action for Reishi mycelia involve its bioactive polysaccharides and triterpenoids. These compounds are believed to modulate immune responses, potentially through the activation of macrophages and regulation of cytokine production. The observed influence on lipid metabolism and liver enzyme activity may be mediated by the mushroom's antioxidant and anti-inflammatory pathways. Reishi interacts with the immune system by enhancing innate immunity. Furthermore, there is evidence suggesting it can regulate the composition of gut microbiota, which in turn may impact metabolic and cardiovascular health. Known molecular targets include Toll-like receptors on immune cells, various antioxidant enzymes, and inflammatory mediators. While polysaccharides have limited direct absorption, their effects may be mediated via gut microbiota fermentation and subsequent systemic immune modulation.

Side effects

Reishi mycelia are generally considered possibly safe when taken orally for up to one year (extracts) or 16 weeks (powdered whole mushroom). Common side effects, reported in over 5% of users, include dizziness, dry mouth, itching, nausea, stomach upset, and rash. Uncommon side effects are not well documented, but rare side effects, occurring in less than 1% of users, may include a potential bleeding risk, particularly in susceptible individuals. Reishi may increase the risk of bleeding, especially when taken concurrently with anticoagulants or in individuals with pre-existing bleeding disorders. Therefore, it is contraindicated in individuals with bleeding disorders and should be used with caution or avoided before surgery. Insufficient data exist regarding the safety of Reishi in pregnant or breastfeeding women, so its use is not recommended in these populations. Always consult a healthcare professional before starting Reishi, especially if you have underlying health conditions or are taking other medications.

Dosage

There is no universally established minimum effective dose for Reishi mycelia, as clinical studies vary widely in their preparations and dosages. Generally, Ganoderma lucidum supplements, including mycelial powder or extracts, are taken in doses ranging from 1 to 3 grams daily. However, specific dosing recommendations for mycelia alone are not standardized. While a clear maximum safe dose has not been defined, safety data support its use for up to one year at the doses studied. Supplements are typically taken daily, often with meals. Reishi is available in various forms, including capsules, powders, or extracts, which may be standardized for their polysaccharide or triterpenoid content. The bioavailability of its compounds may be enhanced by specific extraction methods, and the activity of polysaccharides may partly depend on gut microbiota for fermentation. No specific cofactors are identified as necessary for its efficacy.

FAQs

Is Reishi mycelia effective for cholesterol?

Some evidence suggests modest cholesterol reduction in healthy adults, but this effect is not consistently observed in individuals with metabolic syndrome or diabetes.

Is it safe to take long-term?

Reishi mycelia are considered possibly safe for up to one year of use. It's important to monitor for side effects and avoid if you have a bleeding risk.

When will benefits appear?

Observed benefits typically appear after several weeks to a few months of consistent, regular use.

Can it replace medications?

No, Reishi mycelia should not replace prescribed medications for conditions like high cholesterol, diabetes, or any other medical condition.

Are fruiting bodies better than mycelia?

Both fruiting bodies and mycelia contain bioactive compounds, but their compositions differ. Clinical evidence is more abundant for whole mushroom or fruiting body extracts.

Research Sources

https://onlinelibrary.wiley.com/doi/abs/10.1002/fsn3.70423 – This systematic review and meta-analysis, published in 2025, synthesized data from multiple databases to assess the nutritional and metabolic benefits of Ganoderma lucidum, including mycelial extracts. It found pooled evidence supporting some benefits but highlighted significant heterogeneity across studies and emphasized the need for more rigorous randomized controlled trials (RCTs) to confirm findings. The study noted limitations due to variability in extract types and dosages, contributing to moderate quality evidence.
https://jtim.tums.ac.ir/index.php/jtim/article/view/1497 – Published in 2024, this systematic review and meta-analysis focused on the metabolic effects of Ganoderma lucidum, including 13 trials with diverse adult populations. It reported significant reductions in total cholesterol and liver enzyme SGPT in healthy individuals. However, it found no significant lipid changes in groups with metabolic syndrome or diabetes, citing limitations such as small sample sizes, heterogeneity in populations, and variable interventions.
https://www.mdpi.com/1424-2818/15/8/882 – This 2024 review summarized the chemical constituents of Ganoderma lucidum and their associated biological activities. It highlighted the immunomodulatory, antioxidant, and gut microbiota regulatory effects attributed to mycelial components. The review underscored the necessity for further clinical trials to validate the preclinical findings and translate them into confirmed human health benefits.
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1362479/full – This 2024 article discussed the impact of Ganoderma lucidum on gut microbiota, drawing from animal models and preliminary human data. It suggested potential benefits for cardiovascular and gastrointestinal health through microbiota modulation. The authors called for more human randomized controlled trials to validate these findings and establish the clinical relevance of gut flora regulation by Reishi.
https://medlineplus.gov/druginfo/natural/905.html – This MedlinePlus resource provides a general overview of Reishi mushroom, including its traditional uses, potential effectiveness, and safety profile. It notes that Reishi is possibly safe when taken orally for up to one year and lists common side effects such as dizziness, dry mouth, and stomach upset. The resource also highlights potential drug interactions, particularly with anticoagulants, and contraindications for certain populations like pregnant or breastfeeding women.